Pfizer appoints S.Sridhar as MD

In this May 4, 2014 photo, the Pfizer logo is displayed on the exterior of a former Pfizer factory in the Brooklyn borough of New York. Pfizer says it does not intend to make a takeover offer for British drugmaker AstraZeneca. The Monday, May 26, 2014 announcement comes a week after AstraZeneca's board rejected a proposed $119 billion buyout offer from Pfizer, the world's second-biggest drugmaker by revenue. (AP Photo/Mark Lennihan, File)

Pharmaceutical major Pfizer on Friday appointed S Sridhar as its new Managing Director (MD) with immediate effect for a period of five years.

“The Board of Directors of the company has appointed S Sridhar as the Managing Director of the company, with effect from March 18, 2016 for a period of five years,” Pfizer Ltd said in a BSE filing.

Mr. Sridhar has worked as the Chief Financial Officer of the company for seven years and was appointed the Executive Director on the Board in May 2013.

Prior to joining Pfizer, Mr. Sridhar worked as the Finance Director of Diageo India Pvt Ltd.

Mr. Sridhar’s appointment will be subject to the approval of shareholders at the ensuing Annual General Meeting of the company.